TABLE 1.
Outcome | CPT-unexposed infants* (n = 283) | CPT-exposed infants* (n = 1,239) | Total (N = 1,522) | P-value |
---|---|---|---|---|
Malaria (any severity) | 70 (24.7%) | 241 (19.5%) | 311 (20.4%) | 0.03 |
Anemia | 49 (17.3%) | 166 (13.4%) | 215 (14.1%) | 0.08 |
Severe illness or death | 34 (12.0%) | 135 (10.9%) | 169 (11.1%) | 0.59 |
Diarrhea | 11 (3.9%) | 35 (2.8%) | 46 (3.0%) | |
Malaria(severe) | 10 (3.5%) | 14 (1.1%) | 24 (1.6%) | |
Meningitis | 1 (0.4%) | 9 (0.7%) | 10 (0.7%) | |
Pneumonia | 5 (1.8%) | 51 (4.1%) | 56 (3.7%) | |
Febrile illness | 6 (2.1%) | 22 (1.8%) | 28 (1.8%) | |
Vomiting | 0 (0.0%) | 2 (0.2%) | 2 (0.1%) | |
Death | 1 (0.4%) | 2 (0.2%) | 3 (0.2%) | |
Low weight for age (Z score < -2) | 46 (16.3%) | 192 (15.6%) | 238 (15.6%) | 0.75 |
Infants were considered CPT-unexposed if > 36 weeks of age by June 13, 2006; infants were considered CPT-exposed if they reached 6 weeks of age on or after August 15, 2006.
P-value based on chi-square test comparing CPT-exposed and CPT-unexposed groups. CPT = cotrimoxazole preventive therapy